Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Ngs

    Dear Friends,

    I am newbie in sequencing field. I have some questions in my mind.
    (1) Why we prefer illumina more than 454 sequencing, when 454 gives
    400bp reads length compare to ilumina which gives only 150 reads length?
    (2) And a silly question, what does mean 2*150 or 1 * 250 ? I mean what is 1 or 2
    stand for. Is is for single and pair?
    Thank you in advance for answer or just view.

  • #2
    Originally posted by Desai View Post
    Dear Friends,

    I am newbie in sequencing field. I have some questions in my mind.
    (1) Why we prefer illumina more than 454 sequencing, when 454 gives
    400bp reads length compare to ilumina which gives only 150 reads length?
    (2) And a silly question, what does mean 2*150 or 1 * 250 ? I mean what is 1 or 2
    stand for. Is is for single and pair?
    Thank you in advance for answer or just view.
    1) Direct comparison of Illumina and 454: http://www.plosone.org/article/info%...l.pone.0030087

    2) I think it means paired end (2 x 150) vs. single read (1 x 150).

    Comment


    • #3
      Originally posted by Desai View Post
      Dear Friends,

      I am newbie in sequencing field. I have some questions in my mind.
      (1) Why we prefer illumina more than 454 sequencing, when 454 gives
      400bp reads length compare to ilumina which gives only 150 reads length?
      (2) And a silly question, what does mean 2*150 or 1 * 250 ? I mean what is 1 or 2
      stand for. Is is for single and pair?
      Thank you in advance for answer or just view.
      454 actually does a bit better than 400b reads - some users are able to produce close to 1000b reads. Even though Illumina has shorter reads (up to 2X300 on the MiSeq), it beat out 454 for one simple reason - price. Illumina's platforms generate data at a cost of about 1/100th what it would cost to generate on the 454. Roche simply didn't improve their system as fast as the other platforms (Illumina, Ion Torrent and even PacBio). As such, they've made the decision to shut down the platform in 2016.

      You can learn more about the performance specs and costs of the various platforms on our NGS Knowledge Bank.
      AllSeq - The Sequencing Marketplace
      [email protected]
      www.AllSeq.com

      Comment


      • #4
        I got your point. I thought it related to quality means illumina gave better quality than Roche 454.

        Comment


        • #5
          Originally posted by Desai View Post
          I got your point. I thought it related to quality means illumina gave better quality than Roche 454.
          454 has decent quality, but it definitely has a homopolymer issue - strings of the same base are challenging for the detection system to get right, leading to indel errors. Ion Torrent suffers from the same issue (due to similar chemistries), but they've done more to correct it.
          AllSeq - The Sequencing Marketplace
          [email protected]
          www.AllSeq.com

          Comment

          Latest Articles

          Collapse

          • seqadmin
            Recent Innovations in Spatial Biology
            by seqadmin


            Spatial biology is an exciting field that encompasses a wide range of techniques and technologies aimed at mapping the organization and interactions of various biomolecules in their native environments. As this area of research progresses, new tools and methodologies are being introduced, accompanied by efforts to establish benchmarking standards and drive technological innovation.

            3D Genomics
            While spatial biology often involves studying proteins and RNAs in their...
            01-01-2025, 07:30 PM
          • seqadmin
            Advancing Precision Medicine for Rare Diseases in Children
            by seqadmin




            Many organizations study rare diseases, but few have a mission as impactful as Rady Children’s Institute for Genomic Medicine (RCIGM). “We are all about changing outcomes for children,” explained Dr. Stephen Kingsmore, President and CEO of the group. The institute’s initial goal was to provide rapid diagnoses for critically ill children and shorten their diagnostic odyssey, a term used to describe the long and arduous process it takes patients to obtain an accurate...
            12-16-2024, 07:57 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by seqadmin, 01-09-2025, 04:04 PM
          0 responses
          431 views
          0 likes
          Last Post seqadmin  
          Started by seqadmin, 01-09-2025, 09:42 AM
          0 responses
          440 views
          0 likes
          Last Post seqadmin  
          Started by seqadmin, 01-08-2025, 03:17 PM
          0 responses
          452 views
          0 likes
          Last Post seqadmin  
          Started by seqadmin, 01-03-2025, 11:18 AM
          1 response
          50 views
          1 like
          Last Post Tonia
          by Tonia
           
          Working...
          X